Programme
HKT
Room 209
- 19:00
- 19:10
- 19:20
- 19:30
- 19:40
- 19:50
- 20:00
- 20:10
Room 209
-
19:00-20:0519:00-20:05AASLD-IDDF- HKASLD Joint Symposium – Hot Topics in Chronic Hepatitis BBy: Anna LOK, Robert GISHRoom 209AASLD-IDDF- HKASLD Joint Symposium – Hot Topics in Chronic Hepatitis B19:00-19:0519:05-19:35Debate: Patients who are on antiviral therapy for chronic hepatitis B and have low HCC risk scores can stop HCC screeningAnna LOKUniversity of Michigan, Ann Arbor, Michigan, USA
- Dame Sheila Sherlock Distinguished University Professor
- Alice Lohrman Andrews Research Professor of Hepatology
- Professor of Internal Medicine
- Director of Clinical Hepatology
- Assistant Dean for Clinical Research
19:50-20:05Will new HBV biomarkers help us select agents to cure HBV?Robert GISHUniversity of Nevada School of Medicine, Las Vegas, USA- Adjunct Professor of Medicine
University of Nevada School of Medicine, Reno, USA- Adjunct Professor of Medicine
University of California San Diego, USA- Adjunct Professor of Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences
Loma Linda University, USA- Clinical Professor of Medicine
Asia Pacific Health Foundation, USA- Medical Director
Hepatitis B Foundation, USA- Medical Director
AASLD-IDDF- HKASLD Joint Symposium – Hot Topics in Chronic Hepatitis B
19:00
Welcome remarks and introduction
19:05
19:35
Does peginterferon have a role in HBV cure programs?
** Programme is subject to change without prior notice
